Get startedLog in
    Picture of Evotec SE logo

    EVT — Evotec SE News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Evotec SE - Evotec Biologics Has Been Selected By BARDA TO Advance Antibody Optimization

    Picture of Evotec SE logoEvotec SE
    23/03/2026 06:36
    March 23 (Reuters) - Evotec SE EVTG.DE:

EVOTEC SE - SEATTLE-BASED SUBSIDIARY AND CDMO, JUST - EVOTEC BIOLOGICS, INC., HAS BEEN SELECTED BY BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA)

EVOTEC SE - PROGRAM AWARD VALUED AT UP TO $10 MILLION IF ALL OPTIONS ACTIVATED

EVOTEC SE - TO ADVANCE MANUFACTURING OPTIMIZATION FOR A MONOCLONAL ANTIBODY COCKTAIL TARGETING FILOVIRUS DISEASES, INCLUDING EBOLA VIRUS AND SUDAN VIRUS

Source text: ID:nEQ3BsTgka

Further company coverage: EVTG.DE

 (Gdansk Newsroom)

 (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))

    Recent news on Evotec SE

    See all news